most common glp-1 receptor agonists Market Overview: GLP-1 Agonists and

HUs research on neuroprotection and purinergic signaling has been supported by National Council for Scientific and Technological Development (CNPq)the CNPq-funded National Institute of Science and Technology (INCT) for Purinergic Signaling: Challenges for 21st Century Health (CNPq, Grant No

may also have weight-related indications depending on authorisations/labels) The difference between GLP-1 medicines and supplements GLP-1 medicines are medicines with well-defined active ingredients (e.g

K., & OBrien, K

Funding The author(s) declare financial support was received for the research and/or publication of this article

Amprion D

However, Warner and Phaff note that ALCAR shouldnt replace traditional treatments or therapy, and its best used as a supportive addition alongside other healthy lifestyle habits